ArticleProceedings of the National Academy of Sciences of the United States of America2023

IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing.

Yang Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.